Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""hepatitis c"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 140411

Starter badań:

Tytuł:
Prevalence of hepatitis B and C infection and linkage to care among patients with Non-Communicable Diseases in three rural Rwandan districts: a retrospective cross-sectional study.
Autorzy:
Musafiri T; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda. .; Department of Public Health, Mount Kenya University, Kigali, Rwanda. .
Kamali I; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Kayihura C; Department of Public Health, Mount Kenya University, Kigali, Rwanda.
de la Paix Gakuru J; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Nyirahabihirwe F; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Nizeyimana E; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Kandamage P; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Habinshuti P; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Sekagarura R; Ministry of Health, Butaro District Hospital Cancer Center of Excellence, Burera, Rwanda.
Makuza JD; Rwanda Biomedical Centre, HIV, STIs, Viral Hepatitis and OVDC Division, Kigali, Rwanda.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Karema N; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Serumondo J; Rwanda Biomedical Centre, HIV, STIs, Viral Hepatitis and OVDC Division, Kigali, Rwanda.
Ntakirutimana T; Department of Public Health, Mount Kenya University, Kigali, Rwanda.; School of Public Health, College of Medecine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Ndahimana JD; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
Barnhart DA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.; Laterite Data, Research, and Analytics, Nairobi, Kenya.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 23; Vol. 24 (1), pp. 247. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Noncommunicable Diseases*/epidemiology
Hepatitis B*/diagnosis
Hepatitis C*/diagnosis
Humans ; Aged ; Prevalence ; Cross-Sectional Studies ; Rwanda/epidemiology ; Hepatitis B Surface Antigens ; Retrospective Studies ; Hepacivirus ; Hepatitis C Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings.
Autorzy:
Kamga Wouambo R; Faculty of Science, Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon. .; American Society for Microbiology (ASM), ASM Cameroon, Bangangte, Cameroon. .
Panka Tchinda G; American Society for Microbiology (ASM), ASM Cameroon, Bangangte, Cameroon.; Ecole de Santé Publique, Université Libre de Bruxelles, Bruxelles, Belgium.
Kagoue Simeni LA; American Society for Microbiology (ASM), ASM Cameroon, Bangangte, Cameroon.; Department of Microbiology, Faculty of Health Science, University of Buea, Buea, Cameroon.
Djouela Djoulako PD; American Society for Microbiology (ASM), ASM Cameroon, Bangangte, Cameroon.; Faculty of Medicine, Sorbonne University, Paris, France.
Yateu Wouambo CI; Adventist Cosendai University, Yaounde, Cameroon.
Tamko Mella GF; Laboratory of Fundamental Virology, Centre for Research on Emerging and Reemerging Diseases (CREMER), Yaounde, Cameroon.
Tchoumi Leuwat EP; Yaounde Central Hospital, Yaounde, Cameroon.
Bello D; Faculty of Science, Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
Fokam J; Faculty of Health Sciences, University of Buea, Buea, Cameroon.; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaounde, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Dec 13; Vol. 23 (1), pp. 875. Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/epidemiology
Liver Neoplasms*/pathology
Hepatitis C*/complications
Hepatitis C*/epidemiology
Hepatitis C*/diagnosis
HIV-1*
Hepatitis B*/complications
Hepatitis B*/epidemiology
Hepatitis B*/diagnosis
Male ; Aged ; Humans ; Female ; Adult ; Hepatitis B Surface Antigens ; Hepatitis C Antibodies ; Rural Population ; Cameroon ; Resource-Limited Settings ; Hepacivirus ; HIV Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A single site study to investigate the current prevalence of anti-hepatitis C virus antibody among substance use disorder patients in Hiroshima-Insufficient testing and diagnosis.
Autorzy:
Kagaya A; KONUMA Memorial Institute of Addiction and Mental Health, Hiroshima, Japan.
Nagaoki Y; Department of Gastroenterology, Mazda Hospital, Mazda Motor Corporation, Hiroshima, Japan.
Shimura S; AbbVie GK, Tokyo, Japan.
Kawana K; AbbVie GK, Tokyo, Japan.
Chayama K; Department of Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2023 Dec; Vol. 43 (4), pp. 521-531. Date of Electronic Publication: 2023 May 16.
Typ publikacji:
Journal Article
MeSH Terms:
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Hepatitis C*/drug therapy
Substance-Related Disorders*/diagnosis
Substance-Related Disorders*/epidemiology
Substance-Related Disorders*/complications
Humans ; Prevalence ; Hepatitis C Antibodies/therapeutic use ; Seroepidemiologic Studies ; Hepacivirus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multi-disciplinary cooperation for the micro-elimination of hepatitis C in China: a hospital-based experience.
Autorzy:
Zheng L; Department of Prevention and Healthcare, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou, Fuzhou, Fujian, 350001, P. R. China.
Zhang X; Department of Laboratory Medicine, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou, Fuzhou, Fujian, 350001, P. R. China.
Nian Y; Department of Prevention and Healthcare, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou, Fuzhou, Fujian, 350001, P. R. China.
Zhou W; Department of Laboratory Medicine, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou, Fuzhou, Fujian, 350001, P. R. China.
Li D; Department of Gastroenterology, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou, Fuzhou, Fujian, 350001, P. R. China.
Wu Y; Department of Medical Affair, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou, Fuzhou, Fujian, 350001, P. R. China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Nov 11; Vol. 23 (1), pp. 386. Date of Electronic Publication: 2023 Nov 11.
Typ publikacji:
Journal Article
MeSH Terms:
Hepacivirus*/genetics
Hepatitis C*/diagnosis
Hepatitis C*/prevention & control
Hepatitis C*/drug therapy
Humans ; Retrospective Studies ; Hospitals ; Hepatitis C Antibodies/therapeutic use ; RNA/therapeutic use ; China ; Antiviral Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[Prevalence of viral hepatitis B and C in men who have sex with men enrolled in a demonstration study of pre-exposure prophylaxis for HIV in Cotonou, Benin].
Autorzy:
Béhanzin L; École Nationale de Formation des Techniciens Supérieurs en Santé Publique et en Surveillance Epidémiologique, Université de Parakou, Parakou, Bénin.; Organisation pour la Promotion de la Santé et le Développement Communautaire, Cotonou, Bénin.; Dispensaire IST, Centre de Santé Communal de Cotonou 1, Cotonou, Bénin.
Diabaté S; Centre de Recherche du CHU de Québec-Université Laval, Québec, Canada.; Département de Médecine Sociale et Préventive, Université Laval, Québec, Canada.; UFR Sciences Médicales, Université Alassane Ouattara, Bouaké, Côte d´Ivoire.
Guédou FA; Organisation pour la Promotion de la Santé et le Développement Communautaire, Cotonou, Bénin.; Dispensaire IST, Centre de Santé Communal de Cotonou 1, Cotonou, Bénin.
Matsétsé EG; Organisation pour la Promotion de la Santé et le Développement Communautaire, Cotonou, Bénin.; Dispensaire IST, Centre de Santé Communal de Cotonou 1, Cotonou, Bénin.
Olodo M; Organisation pour la Promotion de la Santé et le Développement Communautaire, Cotonou, Bénin.; Dispensaire IST, Centre de Santé Communal de Cotonou 1, Cotonou, Bénin.
Dossouvo A; Dispensaire IST, Centre de Santé Communal de Cotonou 1, Cotonou, Bénin.
Aza-Gnandji M; Organisation pour la Promotion de la Santé et le Développement Communautaire, Cotonou, Bénin.; Dispensaire IST, Centre de Santé Communal de Cotonou 1, Cotonou, Bénin.
Akpaka A; Bénin Synergie Plus, Cotonou, Bénin.
Chagas E; Réseau Sida Bénin, Cotonou, Bénin.
Gangbo F; Programme Santé de Lutte contre le Sida, Cotonou, Bénin.; Faculté des Sciences de la Santé, Université d´Abomey-Calavi, Cotonou, Bénin.
Zannou DM; Centre National Hospitalier Universitaire HMK, Cotonou, Bénin.; Institut National de Santé Publique, Québec, Canada.
Alary M; Centre de Recherche du CHU de Québec-Université Laval, Québec, Canada.; Département de Médecine Sociale et Préventive, Université Laval, Québec, Canada.; Institut National de Santé Publique, Québec, Canada.
Pokaż więcej
Transliterated Title:
Prévalence des hépatites virales B et C chez les hommes ayant des rapports sexuels avec d’autres hommes mobilisés pour une étude de démonstration de la prophylaxie préexposition au VIH à Cotonou, au Bénin.
Źródło:
The Pan African medical journal [Pan Afr Med J] 2023 Nov 09; Vol. 46, pp. 79. Date of Electronic Publication: 2023 Nov 09 (Print Publication: 2023).
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
HIV Infections*/epidemiology
HIV Infections*/complications
Pre-Exposure Prophylaxis*
Sexual and Gender Minorities*
Hepatitis B*/epidemiology
Hepatitis B*/prevention & control
Hepatitis B*/complications
Hepatitis C*/epidemiology
Hepatitis C*/prevention & control
Hepatitis C*/complications
Male ; Humans ; Homosexuality, Male ; Prevalence ; Hepatitis B Surface Antigens ; Coitus ; Cross-Sectional Studies ; Benin/epidemiology ; Hepatitis B virus ; Hepacivirus ; Hepatitis C Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The best anti-HCV S/Co values for reflecting HCV infection in a university hospital in the eastern part of Turkey.
Autorzy:
Dabanlıoğlu B; Erzincan Binali Yıldırım University, Faculty of Medicine, Department of Medical Microbiology, Erzincan, Turkey.
Yılmaz A; Erzincan Binali Yıldırım University, Faculty of Medicine, Department of Medical Microbiology, Erzincan, Turkey.
Akyüz S; Erzincan Binali Yıldırım University, Faculty of Medicine, Department of Medical Microbiology, Erzincan, Turkey.
Gülhan B; Erzincan Binali Yıldırım University, Faculty of Medicine, Department of Medical Microbiology, Erzincan, Turkey.
Pokaż więcej
Źródło:
Journal of infection in developing countries [J Infect Dev Ctries] 2024 Jan 31; Vol. 18 (1), pp. 131-135. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Journal Article
MeSH Terms:
Hepacivirus*/genetics
Hepatitis C*/diagnosis
Humans ; Hepatitis C Antibodies ; Retrospective Studies ; Turkey ; RNA, Viral ; Hospitals ; Sensitivity and Specificity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia.
Autorzy:
Shawky H; Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt.
Tabll AA; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt.
Elshenawy RM; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt.
Helmy NM; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt.
Moustafa RI; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt.
Elesnawy YK; Ahmed Maher Teaching Hospital, Cairo, Egypt.
Abdelghany MM; National Committee for Control of Viral Hepatitis (NCCVH), Ministry of Health and Population, Cairo, Egypt.
El-Abd YS; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt. .
Pokaż więcej
Źródło:
Microbial cell factories [Microb Cell Fact] 2024 Jan 18; Vol. 23 (1), pp. 25. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Glycylglycine*
Hepatitis C*
Humans ; Viremia/diagnosis ; Escherichia coli ; Point-of-Care Systems ; Solubility ; Hepatitis C Antibodies ; Hepacivirus/genetics ; Immunoassay ; Recombinant Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Seroprevalence of hepatitis B, C, and D and associated factors in the semi-isolated Yanomami Amazonian indigenous community.
Autorzy:
Vasconcelos MPA; Centro de Medicina Tropical de Rondônia - CEMETRON, Porto Velho, Rondônia, Brazil.; Laboratório de Imunoparasitologia do Instituto Oswaldo Cruz - IOC/FIOCRUZ, Rio de Janeiro, Rio de Janeiro, Brazil.
Sánchez-Arcila JC; Laboratório de Imunoparasitologia do Instituto Oswaldo Cruz - IOC/FIOCRUZ, Rio de Janeiro, Rio de Janeiro, Brazil.
Peres L; Laboratório de Hepatites Virais do Instituto Oswaldo Cruz - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
de Sousa PSF; Laboratório de Hepatites Virais do Instituto Oswaldo Cruz - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Castro-Alves J; Instituto Nacional de Infectologia Evandro Chagas da Fundação Oswaldo Cruz - FIOCRUZ, Rio de Janeiro, Brazil.
Albuquerque HG; Laboratório de Doenças Parasitárias do Instituto Oswaldo Cruz - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Mendes-Correa MC; Departamento de Moléstias Infecciosas e Parasitárias da Faculdade de Medicina da Universidade de São Paulo - USP, São Paulo, Brazil.
Maia-Herzog M; Laboratório de Referência Nacional em Simulídeos, Oncocercose e Mansonelose, Coleção de Simulídeos do Instituto Oswaldo Cruz - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Lewis-Ximenez LL; Laboratório de Hepatites Virais do Instituto Oswaldo Cruz - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Villar LM; Laboratório de Hepatites Virais do Instituto Oswaldo Cruz - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Oliveira-Ferreira J; Laboratório de Imunoparasitologia do Instituto Oswaldo Cruz - IOC/FIOCRUZ, Rio de Janeiro, Rio de Janeiro, Brazil. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Jan 02; Vol. 24 (1), pp. 15. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B*/epidemiology
Hepatitis B*/diagnosis
Hepatitis, Viral, Human*/epidemiology
Vaccines*
Hepatitis C*/epidemiology
Child ; Humans ; Adolescent ; Hepatitis B Surface Antigens ; Seroepidemiologic Studies ; Cross-Sectional Studies ; Hepatitis B Antibodies ; Hepatitis B virus ; Hepatitis C Antibodies ; Prevalence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies.
Autorzy:
Gomez-Escobar E; Inserm U1259 MAVIVH, Université de Tours and CHRU de Tours, 37000 Tours, France.
Roingeard P; Inserm U1259 MAVIVH, Université de Tours and CHRU de Tours, 37000 Tours, France.
Beaumont E; Inserm U1259 MAVIVH, Université de Tours and CHRU de Tours, 37000 Tours, France.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 May 11; Vol. 15 (5). Date of Electronic Publication: 2023 May 11.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis C, Chronic*/prevention & control
Hepatitis C*
Viral Hepatitis Vaccines*
Humans ; Antibodies, Neutralizing ; Viral Envelope Proteins/metabolism ; Antiviral Agents/metabolism ; Hepacivirus ; Hepatitis C Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA.
Autorzy:
Hansoongnern P; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pratedrat P; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Nilyanimit P; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Wasitthankasem R; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; National Biobank of Thailand, National Science and Technology Development Agency, Pathum Thani, Thailand.
Posuwan N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Wanlapakorn N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Kodchakorn K; Thailand Excellence Center for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Kongtawelert P; Thailand Excellence Center for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Pimsing N; Non-Communicable Disease Control Group, Phetchabun Provincial Health Office, Phetchabun, Thailand.
Poovorawan Y; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Fellow of the Royal Society of Thailand (FRS[T]), the Royal Society of Thailand, Sanam Sueapa, Bangkok, Thailand.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jun 29; Vol. 18 (6), pp. e0287694. Date of Electronic Publication: 2023 Jun 29 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis C*/diagnosis
Liver Neoplasms*
Humans ; Hepacivirus/genetics ; Amino Acid Substitution ; Hepatitis C Antigens/genetics ; Hepatitis C Antibodies ; RNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study.
Autorzy:
Anwar I; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, ISSPAM, Marseille, France. .
Donadille C; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Protopopescu C; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Michels D; AIDES, Pantin, France.; Laboratoire de Recherche Communautaire, Coalition PLUS, Pantin, France.
Herin J; Bus 31/32, Marseille, France.
Pladys A; Coordination Nationale des Réseaux de Microstructures (CNRMS), Strasbourg, France.
Bader D; Coordination Nationale des Réseaux de Microstructures (CNRMS), Strasbourg, France.
Carrieri P; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Roux P; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Pokaż więcej
Źródło:
Harm reduction journal [Harm Reduct J] 2023 Jul 29; Vol. 20 (1), pp. 98. Date of Electronic Publication: 2023 Jul 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Male ; Humans ; Female ; Hepacivirus ; Cross-Sectional Studies ; Analgesics, Opioid ; Hepatitis C Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Updated Operational Guidance for Implementing CDC's Recommendations on Testing for Hepatitis C Virus Infection.
Autorzy:
Cartwright EJ
Patel P
Kamili S
Wester C
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2023 Jul 14; Vol. 72 (28), pp. 766-768. Date of Electronic Publication: 2023 Jul 14.
Typ publikacji:
Journal Article
MeSH Terms:
Hepacivirus*/genetics
Hepatitis C*/diagnosis
Hepatitis C*/prevention & control
United States ; Humans ; Centers for Disease Control and Prevention, U.S. ; Mass Screening ; RNA ; Hepatitis C Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain.
Autorzy:
Palom A; Departamento de Hepatología, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, 28029 Madrid, Spain.
Almandoz E; Departamento de Enfermedades Gastrointestinales, Hospital Universitario Donostia, Instituto de Investigación Biodonostia, 20014 San Sebastian, Spain.
Madejón A; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, 28029 Madrid, Spain.; Departamento de Hepatología, Hospital Universitario La Paz, IdiPAZ, 28046 Madrid, Spain.
Rando-Segura A; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, 28029 Madrid, Spain.; Departamento de Microbiología, Laboratorios Clínicos, Hospital Universitario Vall d'Hebron, 08035 Barcelona, Spain.
Pérez-Castaño Y; Departamento de Digestivo, Hospital Bidasoa de Hondarribia, Instituto de Investigación Biodonostia, 20280 San Sebastian, Spain.
Vico J; Departamento de Hepatología, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
Gándara S; Departamento de Hepatología, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
Battulga N; Departamento de Hepatología, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
Gómez-I-Prat J; Equipo de Salud Pública y Comunitaria (ESPIC), Unidad de Salud Internacional Drassanes-Hospital Vall d'Hebron, 08001 Barcelona, Spain.
Riveiro-Barciela M; Departamento de Hepatología, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, 28029 Madrid, Spain.
Arenas Ruiz-Tapiador J; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, 28029 Madrid, Spain.; Policlínica Gipuzkoa-Quiron Salud, 20012 San Sebastian, Spain.
García-Samaniego J; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, 28029 Madrid, Spain.; Departamento de Hepatología, Hospital Universitario La Paz, IdiPAZ, 28046 Madrid, Spain.
Buti M; Departamento de Hepatología, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, 28029 Madrid, Spain.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jul 05; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Coinfection*
Hepatitis B*/diagnosis
Hepatitis B*/epidemiology
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Hepatitis A*
Hepatitis D*
Adult ; Humans ; Female ; Male ; DNA, Viral ; Spain/epidemiology ; Hepatitis B virus/genetics ; Hepatitis B Surface Antigens ; Hepatitis C Antibodies ; RNA ; Prevalence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
Autorzy:
Baliashvili D; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, United States of America.
Blumberg HM; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, United States of America.; Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia, United States of America.; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Gandhi NR; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, United States of America.; Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia, United States of America.; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Averhoff F; Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Benkeser D; Department of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Atlanta, Georgia, United States of America.
Shadaker S; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Gvinjilia L; Eastern Europe and Central Asia Regional Office, Centers for Disease Control and Prevention, Tbilisi, Georgia.
Turdziladze A; National Center for Disease Control and Public Health, Tbilisi, Georgia.
Tukvadze N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Chincharauli M; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Butsashvili M; Health Research Union and Clinic NeoLab, Tbilisi, Georgia.
Sharvadze L; Clinic 'Hepa', Tbilisi, Georgia.; The University of Georgia, Tbilisi, Georgia.
Tsertsvadze T; Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
Zarkua J; Clinic 'Mrcheveli', Tbilisi, Georgia.
Kempker RR; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2023 May 04; Vol. 20 (5), pp. e1004121. Date of Electronic Publication: 2023 May 04 (Print Publication: 2023).
Typ publikacji:
Observational Study; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Tuberculosis*/epidemiology
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Tuberculosis, Multidrug-Resistant*
Adult ; Humans ; Adolescent ; Hepacivirus ; Georgia/epidemiology ; Hepatitis C Antibodies ; Viremia ; Cohort Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improved detection of hepatitis C virus-positive blood donors and determination of infection status.
Autorzy:
Nishiya AS; Fundação Pró-Sangue Hemocentro de São Paulo, São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Oncoimmunohematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
de Almeida-Neto C; Fundação Pró-Sangue Hemocentro de São Paulo, São Paulo, Brazil.; Disciplina de Ciências Médicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
Witkin SS; Instituto de Medicina Tropical da Universidade de São Paulo, São Paulo, Brazil.; Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York, USA.
Ferreira SC; Fundação Pró-Sangue Hemocentro de São Paulo, São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Oncoimmunohematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Salles NA; Fundação Pró-Sangue Hemocentro de São Paulo, São Paulo, Brazil.
Nogueira FAH; Fundação Pró-Sangue Hemocentro de São Paulo, São Paulo, Brazil.
Oliveira CDL; Faculdade de Medicina, Universidade Federal de São João del-Rei, São João del-Rei, Brazil.
Rocha V; Fundação Pró-Sangue Hemocentro de São Paulo, São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Oncoimmunohematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.; Disciplina de Ciências Médicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.; Churchill Hospital, Oxford University, Oxford, UK.
Mendrone Júnior A; Fundação Pró-Sangue Hemocentro de São Paulo, São Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Oncoimmunohematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Pokaż więcej
Źródło:
Transfusion medicine (Oxford, England) [Transfus Med] 2023 Apr; Vol. 33 (2), pp. 159-164. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Donors*
Hepatitis C*/diagnosis
Humans ; Hepacivirus ; Retrospective Studies ; Cross-Sectional Studies ; Hepatitis C Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs.
Autorzy:
Ponnuvel S; Department of Clinical Virology, Christian Medical College, Vellore, India.
Prakash A; Department of Clinical Virology, Christian Medical College, Vellore, India.
Steve RJ; Department of Clinical Virology, Christian Medical College, Vellore, India.
Doss GP; Department of Integrative Biology, Vellore Institute of Technology, Vellore, India.
Goel A; Department of Hepatology, Christian Medical College, Vellore, India.
Zachariah UG; Department of Hepatology, Christian Medical College, Vellore, India.
Eapen CE; Department of Hepatology, Christian Medical College, Vellore, India.
Rebekah G; Department of Biostatistics, Christian Medical College, Vellore, India.
Kannangai R; Department of Clinical Virology, Christian Medical College, Vellore, India.
Fletcher GJ; Department of Clinical Virology, Christian Medical College, Vellore, India.
Abraham P; Department of Clinical Virology, Christian Medical College, Vellore, India.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Feb 17; Vol. 18 (2), pp. e0282013. Date of Electronic Publication: 2023 Feb 17 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents*/therapeutic use
Hepatitis C, Chronic*/drug therapy
Humans ; Longitudinal Studies ; RNA, Viral/genetics ; Hepacivirus/genetics ; Hepatitis C Antigens ; Recurrence ; Genotype
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Gender differences in prevalence of hepatitis C virus infection in Egypt: a systematic review and meta-analysis.
Autorzy:
Abdel-Gawad M; Hepatology, Gastroenterology, and Infectious Diseases Department, Assiut Faculty of Medicine, Al-Azhar University, Assiut, Egypt.
Nour M; Department of Public Health and Community Medicine, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.; Faculty of Public Health and Health Informatics, Umm Al-Qura University, Mecca, Saudi Arabia.
El-Raey F; Hepatogastroenterology and Infectious Diseases Department, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Nagdy H; Internal Medicine Department, College of Medicine, Arab Academy for Science and Technology and Maritime Transport, Alexandria, Egypt.
Almansoury Y; Internal Medicine Department, Gastroenterology and Hepatology Division, South Valley University, Qena, Egypt.
El-Kassas M; Endemic Medicine Department, Faculty of Medicine, Helwan University, Ain Helwan, Cairo, 11795, Egypt. m_.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Feb 13; Vol. 13 (1), pp. 2499. Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepacivirus*
Hepatitis C*
Adult ; Child ; Humans ; Male ; Female ; Egypt/epidemiology ; Hepatitis C Antibodies ; Prevalence ; Seroepidemiologic Studies ; RNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study.
Autorzy:
Druckrey-Fiskaaen KT; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway. .; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. .
Vold JH; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Madebo T; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Respiratory Medicine, Stavanger University Hospital, Stavanger, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.
Midgard H; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.
Dalgard O; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.
Leiva RA; Department of Infectious Diseases, Haukeland University Hospital, Bergen, Norway.
Fadnes LT; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Pokaż więcej
Corporate Authors:
INTRO-HCV Study Group
Źródło:
Substance abuse treatment, prevention, and policy [Subst Abuse Treat Prev Policy] 2024 Mar 26; Vol. 19 (1), pp. 21. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/pathology
Hepatitis C, Chronic*/epidemiology
Hepatitis C*/complications
Substance-Related Disorders*/complications
Humans ; Child ; Prospective Studies ; Liver/pathology ; Liver Cirrhosis/epidemiology ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis.
Autorzy:
Mei T; Interventional Therapy Center for Oncology Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Huang X; Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Tang S; Department of Liver Disease, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Liu M; State Clinical Drug Trial Institution, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Zhang W; State Clinical Drug Trial Institution, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Yu H; State Clinical Drug Trial Institution, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. .
Pokaż więcej
Źródło:
Lipids in health and disease [Lipids Health Dis] 2024 Mar 09; Vol. 23 (1), pp. 74. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Humans ; Antiviral Agents/therapeutic use ; Hepacivirus/genetics ; Lipids
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study.
Autorzy:
Passos-Castilho AM; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
Murphy DG; Laboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC H9X 3R5, Canada.
Blouin K; Unité sur les Infections Transmissibles Sexuellement et par le Sang, Institut National de Santé Publique du Québec, Québec, QC H9X 3R5, Canada.
Benedetti A; Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC H3A 1G1, Canada.
Panagiotoglou D; Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC H3A 1G1, Canada.
Bruneau J; CHUM Research Centre, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0A9, Canada.
Klein MB; Research Institute of the McGill University Health Centre, Montreal, QC H3H 2R9, Canada.
Kwong JC; Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada.; ICES, Toronto, ON M4N 3M5, Canada.; Public Health Ontario, Toronto, ON M5G 1M1, Canada.; Department of Family and Community Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada.
Sander B; ICES, Toronto, ON M4N 3M5, Canada.; Public Health Ontario, Toronto, ON M5G 1M1, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2C4, Canada.; Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto, Toronto, ON M5T 3M6, Canada.
Janjua NZ; School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Greenaway C; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.; Division of Infectious Diseases, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Mar 01; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Humans ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use ; Retrospective Studies ; Cohort Studies ; Canada/epidemiology ; RNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 140411

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies